Status:
TERMINATED
Evaluation of Medasense's PMD-200 During Surgery and Post Anesthesia Care
Lead Sponsor:
Medasense Biometrics Ltd
Conditions:
Surgery
Nociceptive Pain
Eligibility:
All Genders
18-75 years
Brief Summary
Medasense's Pain Monitoring Device (PMD) is a novel non-invasive, bedside stand alone, continuous monitor that is designed to provide real-time information about changes in the nociception level of pa...
Detailed Description
The aim of this observational study is to evaluate the pattern of the NOL index during surgery in the anesthetized patient and during the post-operative period in the awake patient. Up to 100 patient...
Eligibility Criteria
Inclusion
- Both genders
- Age 18 - 75 years
- ASA physical status 1-3
- Elective surgery
Exclusion
- History of severe cardiac arrhythmia
- Abuse of alcohol or illicit drugs
- Preoperative opioid consumption for \> 1 week
- History of mental retardation or any mental disease diagnosis
- Under sedation protocol - Patients with difficult spontaneous ventilation ( for e.g. patients with sleep apnea) will be excluded.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2019
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT03276260
Start Date
January 1 2018
End Date
April 30 2019
Last Update
March 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus
Haifa, Israel, 31096